Dexcom (DXCM) Interest Coverage Ratio Growth (5y) (2015 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 87.65% |
| Mar 31, 2023 | 29.23% |
| Dec 31, 2022 | 59.89% |
| Sep 30, 2022 | 210.92% |
| Jun 30, 2022 | 41.81% |
| Mar 31, 2022 | 16.12% |
| Dec 31, 2021 | 14.94% |
| Sep 30, 2021 | 17.90% |
| Jun 30, 2021 | 16.05% |
| Mar 31, 2021 | 15.45% |
| Sep 30, 2020 | 14.97% |
| Jun 30, 2020 | 15.92% |
| Mar 31, 2020 | 15.26% |
| Dec 31, 2019 | -3.68% |
| Sep 30, 2019 | 16.53% |
| Jun 30, 2019 | 71.63% |
| Mar 31, 2019 | 56.42% |
| Dec 31, 2018 | -21.23% |
| Sep 30, 2018 | 15.97% |
| Jun 30, 2018 | 53.99% |
| Mar 31, 2018 | 34.85% |
| Dec 31, 2017 | 15.57% |
| Dec 31, 2016 | -15.06% |
| Sep 30, 2016 | 62.98% |
| Jun 30, 2016 | 39.42% |
| Mar 31, 2016 | 37.28% |
| Sep 30, 2015 | -7.39% |
| Jun 30, 2015 | 8.84% |